Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Metatri 35mg Tablet MR

Prescription Icon
Prescription Required

Marketer

Santiago Lifesciences Pvt Ltd

Salt Composition

Trimetazidine (35mg)

Overview Metatri 35mg Tablet MR

Cardoxin 35mg Extended-Release Tablets are prescribed for angina pectoris, a type of chest pain stemming from heart conditions. This medication acts as a preventative measure against angina episodes but is ineffective once an attack begins. It can be administered independently or alongside other cardiac medications. Dosage and frequency of Cardoxin 35mg Extended-Release Tablets should strictly adhere to your physician's instructions, taken consistently with or without food. Your doctor may adjust the prescribed schedule based on your response to treatment. Continuous use, even during symptom-free periods, is crucial for maximizing efficacy and minimizing future cardiac events. Discontinuing treatment may trigger a recurrence of chest pain. Complementing medication with a heart-healthy lifestyle – including smoking cessation, moderate alcohol consumption, a balanced diet, regular physical activity, and stress management – is strongly recommended. Potential side effects, such as nausea, vomiting, abdominal discomfort, diarrhea, headache, dizziness, skin rashes (including hives and itching), and weakness, may occur. Report any persistent or bothersome side effects to your doctor. Prior to commencing treatment, inform your doctor of any pre-existing liver or kidney conditions, pregnancy, breastfeeding, or other concurrent medications you are using.

Uses of Metatri 35mg Tablet MR

Managing chest pain associated with angina pectoris

Major Benefits of Metatri 35mg Tablet MR:

Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Metatri 35mg Modified-Release Tablet should be administered with a meal.

Common Side effects of Metatri 35mg Tablet MR:

  • Dizziness
  • Headache
  • Nausea
  • Vomiting
  • Weakness
  • Rash
  • Abdominal pain
  • Indigestion
  • Itching
  • Diarrhea
  • Hives

How to use Metatri 35mg Tablet MR:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Metatri 35mg Modified-Release Tablet should be taken with a meal.

How Metatri 35mg Tablet MR works:

Metatri 35mg Modified-Release tablets are used to treat angina. They reduce the heart's oxygen demand by altering its metabolic processes, favoring glucose over fats. This improves the heart's overall functionality.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of Metatri 35mg Modified-Release tablets and alcohol may result in significant sleepiness.

PregnancyPregnancyCONSULT YOUR DOCTOR

Data on Metatri 35mg Tablet MR use in pregnancy is lacking. Seek medical advice from your physician.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Data on the safety of Metatri 35mg Modified-Release tablets while breastfeeding is lacking. Seek medical advice from your physician.

DrivingDrivingUNSAFE

Taking a Metatri 35mg Modified-Release tablet may cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these effects.

KidneyKidneyCAUTION

For individuals with kidney impairment, Metatri 35mg Modified-Release tablets require careful administration and may necessitate dosage modification. Consult your physician for guidance. Metatri 35mg Modified-Release tablets are contraindicated in patients experiencing severe kidney disease.

LiverLiverCONSULT YOUR DOCTOR

Data regarding the use of Metatri 35mg Tablet MR in individuals with hepatic impairment is scarce. Physician consultation is advised.

What if you forget to take Metatri 35mg Tablet MR :

Should you forget a dose of Metatri 35mg Modified-Release Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Metatri 35mg Tablet MR

LabelValue
Chemical Type Benzylamines
Developing Habits No.
Treatment Category HEART
Action Class Fatty acid modifier and sodium channel inhibitor

FAQs on Metatri 35mg Tablet MR

Metatri 35mg Tablet MR isn't a beta-blocker; it's an anti-anginal drug. Used alongside other medications, it treats angina pectoris (chest pain from coronary artery disease) by safeguarding heart cells from oxygen deprivation during angina attacks.
Metatri 35mg Tablet MR is contraindicated in patients with allergies to the drug or severe kidney disease. Individuals with Parkinson's disease, a neurological disorder affecting movement and characterized by tremors, rigidity, bradykinesia, and postural instability, should also avoid this medication.
For patients over 75, Metatri 35mg MR tablets require careful use and typically a lower dose to minimize potential side effects. Close monitoring of these patients is essential.
Metatri 35mg Tablet MR can rarely cause falls, potentially due to gait instability or postural hypotension. Elderly patients may be at increased risk and require closer supervision.
Metatri 35mg Tablet MR can cause dizziness and drowsiness. Avoid driving or operating machinery if you experience these side effects.
Follow your doctor's instructions precisely when taking Metatri 35mg Tablet MR. Take the tablets orally, with enough liquid such as water. This medication can be taken with or without food.
Metatri 35mg Tablet MR may cause dizziness, headache, abdominal pain, diarrhea, indigestion, hives, rash, and itching. Some users experience nausea and weakness. Rarely, it can lead to palpitations, orthostatic hypotension (causing dizziness, lightheadedness, or fainting), falls, and flushing.
Metatri 35mg Tablet MR
111
MRP 135
17% off